Tissue-specific expression of the vasoactive intestinal peptide gene requires both an upstream tissue specifier element and the 5' proximal cyclic AMP-responsive element

Journal of Neurochemistry

Volumn 67, Issue 5, 1996, Pages 1872-1881

  Hahm, Sung Ho ^a   Eiden, Lee E ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Cyclic AMP responsive element; Gene expression; Neuroblastoma cells; Protein kinase C; Signal transduction; Vasoactive intestinal peptide

Indexed keywords

FORSKOLIN; PHORBOL 13 ACETATE 12 MYRISTATE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; BINDING SITE; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; ENHANCER REGION; GENE EXPRESSION REGULATION; GENE SEQUENCE; HUMAN; HUMAN CELL; NEUROMODULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; SECOND MESSENGER; TISSUE SPECIFICITY;

EID: 0001688843     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67051872.x     Document Type: Article

References (35)

1. Adler E. M. and Fink J. S. (1993) Calcium regulation of vasoactive intestinal polypeptide mRNA abundance in SH-SY5Y human neuroblastoma cells. J. Neurochem. 61, 727-737.
2. Angel P. and Karin M. (1991) The role of Jun, Fos and the AP-I complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072, 129-157.
3. Brenneman D. E. and Eiden L. E. (1986) Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc. Natl Acad. Sci. USA 83, 1159-1162.
4. Chatton B., Bocco J. L., Goetz J., Gaire M., Lutz Y., and Kedinger C. (1994) Jun and Fos heterodimerize with ATFa, a member of the ATF/CREB family and modulate its transcriptional activity. Oncogene 9, 375-385.
5. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
6. Clark M. E. and Mellon P. L. (1995) The POU homeodomain transcription factor Oct-1 is essential for activity of the gonadotropin-releasing hormone neuron-specific enhancer. Mol. Cell. Biol. 15, 6169-6177.
7. Delegeane A. M., Ferland L. H., and Mellon P. A. (1987) Tissue-specific enhancer of the human glycoprotein hormone α-subunit gene: dependence on cyclic AMP-inducible elements. Mol. Cell. Biol. 7, 3994-4002.
8. Eiden L. E. and Hotchkiss A. J. (1983) Cyclic adenosine monophosphate regulates vasoactive intestinal polypeptide and enkephalin biosynthesis in cultured bovine chromaffin cells. Neuropeptides 4, 1-9.
9. Fedoroff S. and Hertz L., eds (1983) Advances in Cellular Neurobiology, Vol. 4: Homogeneously Staining Regions and Double Minute Chromosomes. Prevalent Cytogenetic Abnormalities of Human Neuroblastoma Cells. Academic Press, New York.
10. Fink J. S., Verhave M., Kasper S., and Tsukada T. (1988) The CGTCA sequence motif is essential for biological activity of the vasoactive intestinal peptide gene cAMP-regulated enhancer. Proc. Natl. Acad. Sci. USA 85, 6662-6666.
11. Fink J. S., Verhave M., Walton K., Mandel G., and Goodman R. H. (1991) Cyclic AMP- and phorbol ester-induced transcriptional activation are mediated by the same enhancer element in the human vasoactive intestinal peptide gene. J. Biol. Chem. 266, 3882-3887.
12. Georg B., Wulff B. S., and Fahrenkrug J. (1994) Characterization of the effects of retinoic acid on vasoactive intestinal peptide gene expression in neuroblastoma cells. Endocrinology 135, 1455-1463.
13. Gozes I., Giladi E., and Shani Y. (1987a) Vasoactive intestinal peptide gene: putative mechanism of information storage at the RNA level. J. Neurochem. 48, 1136-1141.
14. Gozes I., Shani Y., and Rostene W. H. (1987b) Developmental expression of the VIP-gene in brain and intestine. Brain Res. 388, 137-148.
15. Gozes I., Schächter P., Shani Y., and Giladi E. (1988) Vasoactive intestinal peptide gene expression from embryos to aging rats. Neuroendocrinology 47, 27-31.
16. Gressens P., Hill J. M., Gozes I., Fridkin M., and Brenneman D. E. (1993) Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature 362, 155-158.
17. Hai T. and Curran T. (1991) Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA 88, 3720-3724.
18. Hayakawa Y., Obata K.-I., Itoh N., Yanaihara N., and Okamoto H. (1984) Cyclic AMP regulation of pro-vasoactive intestinal polypeptide/PHM-27 synthesis in human neuroblastoma cells. J. Biol. Chem. 259, 9207-9211.
19. Kasper S., Popescu R. A., Torsello A., Vrontakis M. E., Ikejiani C., and Friesen H. G. (1992) Tissue-specific regulation of vaso-active intestinal peptide messenger ribonucleic acid levels by estrogen in the rat. Endocrinology 130, 1796-1801.
20. Leonard J., Serup P., Gonzalez G., Edlund T., and Montminy M. (1992) The LIM family transcription factor Isl-1 requires cAMP response element binding protein to promote somatostatin expression in pancreatic islet cells. Proc. Natl. Acad. Sci. USA 89, 6247-6251.
21. Li Y.-P., Baskin F., Davis R., Wu D., and Hersh L. B. (1995) A cell type-specific silencer in the human choline acetyltransferase gene requiring two distinctive and interactive E boxes. Mol. Brain Res. 30, 106-114.
22. Lin A., Smeal T., Binetruy B., Deng T., Chambard J. C., and Karin M. (1993) Control of AP-1 activity by signal transduction cascades. Adv. Second Messenger Phosphoprotein Res. 28, 255-260.
23. Meyer T. E. and Habener J. F. (1993) Cyclic adenosine 3′,5′-monophosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid-binding proteins. Endocr. Rev. 14, 269-290.
24. Nobou F., Besson J., Rosténe W., and Rosselin G. (1985) Ontogeny of vasoactive intestinal peptide and somatostatin in different structures of the brain. Dev. Brain Res. 20, 296-301.
25. Pence J. C. and Shorter N. A. (1992) Autoregulation of neuroblastoma growth by vasoactive intestinal peptide. J. Pediatr. Surg. 27, 935-944.
26. Pincus D. W., DiCicco-Bloom E. M., and Black I. B. (1990) Vaso-active intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts. Nature 343, 564-567.
27. Rao M. S., Symes A., Malik N., Shoyab M., Fink J. S., and Landis S. C. (1992) Oncostatin M regulates VIP expression in a human neuroblastoma cell line. Neuroreport 3, 865-868.
28. Rosténe W. H. (1984) Neurobiological and neuroendocrine functions of the vasoactive intestinal peptide (VIP). Prog. Neurobiol. 22, 103-129.
29. Sanger F.. Nicklen S., and Coulson A. R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
30. Steger D. J., Hecht J. H., and Mellon P. L. (1994) GATA-binding proteins regulate the human gonadotropin α-subunit gene in the placenta and pituitary gland. Mol Cell. Biol. 14, 5592-5602.
31. Symes A. J., Rao M. S., Lewis S. E., Landis S. C., Hyman S. E., and Fink J. S. (1993) Ciliary neurotrophic factor coordinately activates transcription of neuropeptide genes in a neuroblastoma cell line. Proc. Natl. Acad. Sci. USA 90, 572-576.
32. Tsukada T., Fink J. S., Mandel G., and Goodman R. H. (1987) Identification of a region in the human vasoactive intestinal polypeptide gene responsible for regulation by cyclic AMP. J. Biol. Chem. 262, 8743-8747.
33. Waschek J. A. (1995) Vasoactive intestinal peptide: an important trophic factor and developmental regulator? Dev. Neurosci. 17, 1-7.
34. Waschek J. A., Hsu C-M., and Eiden L. E. (1988) Lineage-specific regulation of the vasoactive intestinal peptide gene in neuroblastoma cells is conferred by 5.2 kilobases of 5′-flanking sequence. Proc. Natl. Acad. Sci. USA 85, 9547-9551.
35. Wollman Y., Liling G., Goldstein M. N., Fridkin M., and Cozes I. (1993) Vasoactive intestinal peptide: a growth promoter in neuroblastoma cells. Brain Res. 624, 339-341.